Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q1 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −27,231−100.0% | Sold out | Holders |
| Q2 2025 | 27,231 | $255.0K | <0.1% | −45,327−62.5% | Reduced | Holders |
| Q1 2025 | 72,558 | $891.4K | 0.1% | −4,356−5.7% | Reduced | Holders |
| Q4 2024 | 76,914 | $1.02M | 0.1% | +58,844+325.6% | Added | Holders |
| Q3 2024 | 18,070 | $347.8K | <0.1% | +18,070 | New | Holders |